Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Terminated 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 18Lymphoid 4Other hematologic neoplasm 3Thoracic 2Plasma cell 2Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 266Osteosarcoma 81Sarcoma, Ewing 50Neoplasms 43Melanoma 43Gastrointestinal Stromal Tumors 43Colorectal Neoplasms 40Breast Neoplasms 37Bone Neoplasms 37Rhabdomyosarcoma 35Neoplasm Metastasis 32Pancreatic Neoplasms 30Ovarian Neoplasms 30Neuroblastoma 30Stomach Neoplasms 28Dendritic Cell Sarcoma, Interdigitating 27Lung Neoplasms 26Liposarcoma 25Leiomyosarcoma 25Glioblastoma 23Uterine Cervical Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Sarcoma, Synovial 21Head and Neck Neoplasms 21Esophageal Neoplasms 21Sarcoma, Kaposi 19Lymphoma 18Carcinoma, Hepatocellular 18Urinary Bladder Neoplasms 17Prostatic Neoplasms 17

Interventions

pegfilgrastim 1Vincristine 1Rituximab 1Prednisolone 1Lenalidomide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Cardiotoxicity × Sarcoma × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡